Professor Sylvia Haas is a Professor of Medicine and the former Director of the Haemostasis and Thrombosis Research Group at the Institute for Experimental Oncology and Therapy Research, Technical University of Munich in Germany. She studied at the University of Freiburg and the University of Munich.
Professor Haas’s extensive research focused on the development of innovative anticoagulant therapies, laboratory monitoring of anticoagulants, biomarkers, and tumour-associated thrombosis. She is actively involved in several clinical trials centred around the prevention and treatment of arterial and venous thromboembolism.
Professor Haas established the Haemostasis and Thrombosis Research Group at the Institute for Experimental Surgery, now the Institute for Experimental Oncology and Therapy Research, at the Technical University of Munich. She is a fellow of the Southern African Society of Thrombosis and Haemostasis and is also a member of several editorial boards for peer-reviewed journals, including International Angiology and Clinical and Applied Thrombosis/Hemostasis.